Placeholder

2013 PharmaVOICE 100 – Who’s on the List by Company

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Accelrys — Ken Rapp
Acorda Therapeutics— Denise Duca
Acurian— Kristin Gross
Addgene— Dr. Joanne Kamens
Advanced Clinical Concepts — David Rear
Agano Solutions and Auditgraph — Mauricha Marcussen
AmerisourceBergen Corp.— Steve Collis
Arena Pharmaceuticals— Dominic Behan, Ph.D.
Artcraft Health Education — Marc Sirockman
Assay Depot — Kevin Lustig, Ph.D.
athenahealth — Jonathan Bush
aTyr Pharma — John Mendlein, Ph.D.
Bayer Healthcare Dermatology— Kathy Jo Usher
BBK Worldwide— Matthew Stumm
Blue Chip Marketing — Bob Klein
Cegedim— Dave Escalante Jr.
Clinical Research Advantage — David Bruggeman
closerlook— Dave Ormesher
CMI Communcations Media Inc.— Calvin Butts Jr.
Comprehend Systems — Jud Gardner
Downtown Project Las Vegas — Zubin Damania, M.D.
eHealthcare Solutions— R.J. Lewis
EMD Serono— Helen Sabzevari, Ph.D.
Epocrates, an athenahealth company — Jody Blakeway
Ernst & Young — Kim Ramko
ExcoInTouch  — Tim Davis
Genzyme, a Sanofi Company — Jamie Ring
GlaxoSmithKline— Graham Simpson
GlaxoSmithKline — Laura Randa
GlycoMimetics — Rachel King
Greenphire— Samuel Whitaker
GSW — Tim McCort
HCB Health — Kerry Hilton
ICC Lowe Trio  — Renee Wills
IDDI — Marc Buyse
IDEA Pharma— Mike Rea
ImaginAb— Christian Behrenbruch, Ph.D.
Imperial— Steve Swanson
INC Research — Jeff Kueffer
Inovio Pharmaceuticals— Joseph Kim, Ph.D.
IntelliMedicine — Daniel Kraft, M.D.
inVentiv Health Clinical — Pam Strobel
Janssen Research & Development LLC — Daniel Baker, M.D.
Janssen Research & Development LLC— Mark Curran, Ph.D.
JBK Associates — Julie Kampf
Kantar Health  — Mike Kelly
Klick Health — Leerom Segal
JMcCann Regan Campbell Ward — Matthew West
MedAvante — Amy Ellis
MedEvoke — David Segarnick, Ph.D.
Medicus Research/SysteMedicus— Jay Udani, M.D.
Merck — Adrienne Robinson
MicroMass Communications — Jessica Brueggeman
Microsoft — Andrea McGonigle
Millennium Pharmaceuticals Inc.— Fatima Scipione
MIT Media Lab  — Ramesh Raskar
Modular Thermal Technologies Inc.— Art Pirrone
National Institutes of Health  Francis Collins, M.D., Ph.D.
NextDocs— Satwik Seshasai
Novartis— Mark Fishman, M.D.
Novartis — André Wyss
Ogilvy CommonHealth Worldwide — Marc Weiner
OncoSec Medical Inc. — Punit Dhillon
Oracle Health Sciences— Neil de Crescenzo
Organovo— Sharon Presnell, Ph.D.
OvaScience — Scott Chappel, Ph.D.
Palio+Ignite — John Guarino
Patheon — Michael Lehmann
PatientsLikeMe — Jamie Heywood
Planning for Hope — Susan Grant
PRA — Kent Thoelke
Pronutria — David Berry
PSKW — Bob Previdi
Publicis Healthcare Communications Group— Nick Colucci
Publicis Healthcare Communications Group — Alexandra von Plato
Publicis Touchpoint Solutions — Rick Keefer
PwC— Ann Mohamadi
Pyramid Resource Group — DJ Mitsch
Questcor Pharmaceuticals— Jorge Lee
Remedy Health Media— Jim Curtis
Retrophin Inc. — Martin Shkreli
Roska Healthcare — David Zaritsky
RPS Inc.— Dan Perlman
Sanofi Pasteur— Damian Braga
Scientific Advantage LLC— Robin Winter-Sperry, M.D.
Sentrx, a part of Telerx — Doreen Lechner, Ph.D.
Sentrx, a part of Telerx— Michael O’Gorman
Shire — Jeff Jonas
Society for Clinical Research Sites — Christine Pierre
Sunovion Pharmaceuticals — Antony Loebel
Sunovion Pharmaceuticals — Richard Russell
SynteractHCR — Mary Clegg
The Boston Consulting Group — Stefan Larsson
The Medical Affairs Company— David Hahn
The Multiple Myeloma Research Foundation— Walter Capone
Tria Health — Jessica Lea, Pharm.D.
Understand.com— Darik Volpa
United BioSource Corp.— Abbe Steel
Veeva— Brian Longo
WorldOne— Andrew Burns

FEEDBACK